TRVI Stock Analysis: Buy, Sell, or Hold?
TRVI - Trevi Therapeutics, Inc. Common Stock
$19.61
2.25 (12.96%)
▲
5d:
+9.92%
30d:
+27.34%
90d:
+34.87%
BUY
HIGH Confidence
Analysis Updated: Jul 16, 2026 12:00 AM ET
Earnings: Aug 06, 2026
19d
Smart Money Accumulation
None View Scanner →
Strength: 5.2/10
Get Alerted When TRVI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TRVI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: TRVI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: TRVI is currently trading at $19.61, which is considered fair relative to its 30-day fair value range of $15.05 to $18.70.
Technical Outlook: Technically, TRVI is in a strong uptrend. The price is approaching resistance at $20.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 13.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.90 (+37.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TRVI is in a strong uptrend. The price is approaching resistance at $20.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 13.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $23.90 (+37.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$15.05 -
$18.70
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+13.0%)
- BULLISH: Trading 37.7% below Wall St target ($23.90)
Trading Range Analysis
30-Day Trading Range
$15.05 -
$18.70
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$16.24
Resistance Level
$20.15
Current Trend
Strong Uptrend
Technical data as of
Jul 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-31.12
Wall Street Target
$23.90
(+37.7%)
Share & Embed Analysis
Last updated: July 17, 2026 11:08 AM ET
Data refreshes hourly during market hours. Next update: 12:08 PM
Data refreshes hourly during market hours. Next update: 12:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRVI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 53 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 56 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
Advanced TRVI Option Strategies
Professional options setups generated by AI based on today's TRVI price and gamma walls.
